相关实验视频
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
一种快速,可逆和可调节的方法来调节活细胞中的蛋白质功能,使用合成小分子
Laura A Banaszynski1, Ling-Chun Chen, Lystranne A Maynard-Smith
1Department of Chemistry, Stanford University, Stanford, California 94305, USA.
Cell
|September 9, 2006
概括
科学家们开发了一种新方法,利用合成分子控制细胞中的蛋白质稳定性. 这种技术允许快速,可逆和特定的蛋白质调节,有助于生物研究.
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- *精确控制蛋白质功能对于理解复杂的生物系统至关重要.
- * 现有的蛋白质扰动方法往往缺乏速度,可逆性或特异性.
研究的目的:
- * 开发一种通用和可控制的方法来调节哺乳动物细胞中的蛋白质稳定性.
- *使用合成分子使特定蛋白质的条件扰动成为可能.
主要方法:
- * 人类FKBP12蛋白质的工程破坏稳定的突变.
- * 融合这些破坏稳定的域以准感兴趣的蛋白质.
- *利用细胞透的合成配体来控制蛋白质降解.
主要成果:
- *工程FKBP12突变使化蛋白质迅速和构成性地降解.
- *添加合成连接体可以逆转降解,恢复蛋白质功能.
- * 该系统展示了特异性,速度,可逆性和剂量依赖性.
结论:
- * 这种新的策略为蛋白质稳定性提供了前所未有的控制.
- * 该方法在各种实验环境中促进了条件蛋白质扰动.
- * 它为剖析生物通路提供了一个强大的工具.
相关概念视频
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K